Skip to content
Clinical Trials – home

Medical University Of Gdansk

Verifiedinfo

Poland Ul. Debinki 7, 80-211 Gdansk, Poland

  • 7 trials recruiting
  • Hepatoblastoma · Neoplasm malignant · Non-small cell lung cancer metastatic
  • Adults and children

About Specializations

Medical University Of Gdansk in Gdansk, Poland specialises in clinical trials of conditions such as Hepatoblastoma, Neoplasm malignant, Non-small cell lung cancer metastatic, Medullary thyroid cancer, and other specialisations. This site conducts important research.

Main research areas of the site

Cardiovascular Research

The center is at the forefront of cardiovascular research, focusing on innovative treatments for conditions such as Marfan Syndrome and Acute Coronary Syndrome (ACS). The research aims to slow down aortic root dilatation in young patients and explore safer antiplatelet strategies.

  • Marfan Syndrome and related aortic diseases
  • Acute Coronary Syndrome (ACS) management
  • Myocardial Injury after Noncardiac Surgery (MINS)

Through these studies, the center contributes significantly to the development of targeted therapies that improve patient outcomes and reduce cardiovascular risks.

Pediatric Oncology

Specializing in pediatric oncology, the center is dedicated to advancing treatment protocols for primary malignant liver cancer in children. The research focuses on individualizing treatment plans and minimizing side effects while maintaining high cure rates.

  • Hepatoblastoma and Hepatocarcinoma
  • Personalized treatment strategies
  • Reduction of treatment side effects

These efforts aim to enhance the effectiveness of current therapies and improve survival rates for young patients with liver cancer.

Nephrology

The center is pioneering research in nephrology, particularly focusing on idiopathic nephrotic syndrome in children. The studies aim to extend the duration of disease remission and improve the quality of life for affected patients.

  • Idiopathic Nephrotic Syndrome
  • Rituximab treatment efficacy
  • Long-term disease management

By exploring early intervention strategies, the center seeks to provide more effective treatment options for pediatric nephrotic syndrome.

Neurology and Behavioral Sciences

In the realm of neurology, the center is investigating the impact of tuberous sclerosis complex on behavior and seizure management. The research evaluates the effectiveness of add-on therapies in improving behavioral outcomes.

  • Tuberous Sclerosis Complex (TSC)
  • Behavioral outcome improvements
  • Seizure management strategies

These studies aim to enhance the quality of life for individuals with TSC by addressing both neurological and behavioral challenges.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Site location
Ul. Debinki 780-211 GdanskPoland
Recruiting now
7 trials
Conditions studied
16
Partner status
Verified

More sites in GdanskPoland

Recruiting now

Ongoing trials

Clinical trials currently enrolling participants at this site.

Condition
Type of trial
Recruitment status
Quick filters

10 clinical trials

Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Carboplatin
  • Sponsor:Ellipses Pharma Limited
Countries:PolandPoland
  • Participants:0–17 years · 18–64 years
  • Substances:Carboplatin
  • Sponsor:The University Of Birmingham
Investigational
Countries:PolandPoland
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:Clemizole Hydrochloride
  • Sponsor:Epygenix Therapeutics Inc.

Cardiac failure

Recruiting
Registered drug
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Sacubitril
  • Sponsor:Agencja Badań Medycznych
Countries:PolandPoland
  • Participants:0–17 years · 18–64 years
  • Substances:Carboplatin
  • Sponsor:Medical University Of Gdansk
Countries:PolandPoland
  • Participants:0–17 years · 18–64 years
  • Substances:Valsartan
  • Sponsor:Medical University Of Gdansk

Myocardial ischaemia

Not recruiting
Registered drug
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Ivabradine
  • Sponsor:Uniwersytet Jagiellonski Collegium Medicum
Registered drug
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Acetylsalicylic Acid
  • Sponsor:Agencja Badań Medycznych
Countries:PolandPoland
  • Participants:0–17 years · 18–64 years
  • Substances:Cannabidiol
  • Sponsor:Jazz Pharmaceuticals Research UK Limited
Is this your site?

Join our network of research sites

Move up to Verified & featured: your own description, photos and phone number on this page, and top placement on every trial you run.

See the offer for sites
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.